215 related articles for article (PubMed ID: 22130974)
1. Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis.
Suwannalai P; van de Stadt LA; Radner H; Steiner G; El-Gabalawy HS; Zijde CM; van Tol MJ; van Schaardenburg D; Huizinga TW; Toes RE; Trouw LA
Arthritis Rheum; 2012 May; 64(5):1323-8. PubMed ID: 22130974
[TBL] [Abstract][Full Text] [Related]
2. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis.
van de Stadt LA; de Koning MH; van de Stadt RJ; Wolbink G; Dijkmans BA; Hamann D; van Schaardenburg D
Arthritis Rheum; 2011 Nov; 63(11):3226-33. PubMed ID: 21792832
[TBL] [Abstract][Full Text] [Related]
3. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis.
van der Woude D; Rantapää-Dahlqvist S; Ioan-Facsinay A; Onnekink C; Schwarte CM; Verpoort KN; Drijfhout JW; Huizinga TW; Toes RE; Pruijn GJ
Ann Rheum Dis; 2010 Aug; 69(8):1554-61. PubMed ID: 20448290
[TBL] [Abstract][Full Text] [Related]
4. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.
Ioan-Facsinay A; Willemze A; Robinson DB; Peschken CA; Markland J; van der Woude D; Elias B; Ménard HA; Newkirk M; Fritzler MJ; Toes RE; Huizinga TW; El-Gabalawy HS
Arthritis Rheum; 2008 Oct; 58(10):3000-8. PubMed ID: 18821680
[TBL] [Abstract][Full Text] [Related]
5. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
[TBL] [Abstract][Full Text] [Related]
6. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
[TBL] [Abstract][Full Text] [Related]
7. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
van der Woude D; Lie BA; Lundström E; Balsa A; Feitsma AL; Houwing-Duistermaat JJ; Verduijn W; Nordang GB; Alfredsson L; Klareskog L; Pascual-Salcedo D; Gonzalez-Gay MA; Lopez-Nevot MA; Valero F; Roep BO; Huizinga TW; Kvien TK; Martín J; Padyukov L; de Vries RR; Toes RE
Arthritis Rheum; 2010 May; 62(5):1236-45. PubMed ID: 20131291
[TBL] [Abstract][Full Text] [Related]
8. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.
Reynisdottir G; Karimi R; Joshua V; Olsen H; Hensvold AH; Harju A; Engström M; Grunewald J; Nyren S; Eklund A; Klareskog L; Sköld CM; Catrina AI
Arthritis Rheumatol; 2014 Jan; 66(1):31-9. PubMed ID: 24449573
[TBL] [Abstract][Full Text] [Related]
9. Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens.
Suwannalai P; Scherer HU; van der Woude D; Ioan-Facsinay A; Jol-van der Zijde CM; van Tol MJ; Drijfhout JW; Huizinga TW; Toes RE; Trouw LA
Ann Rheum Dis; 2011 Feb; 70(2):373-9. PubMed ID: 21068094
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
[TBL] [Abstract][Full Text] [Related]
11. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
12. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.
Verpoort KN; Jol-van der Zijde CM; Papendrecht-van der Voort EA; Ioan-Facsinay A; Drijfhout JW; van Tol MJ; Breedveld FC; Huizinga TW; Toes RE
Arthritis Rheum; 2006 Dec; 54(12):3799-808. PubMed ID: 17133560
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
[TBL] [Abstract][Full Text] [Related]
14. Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis.
Suwannalai P; Britsemmer K; Knevel R; Scherer HU; Levarht EW; van der Helm-van Mil AH; van Schaardenburg D; Huizinga TW; Toes RE; Trouw LA
Ann Rheum Dis; 2014 Jan; 73(1):270-6. PubMed ID: 23463689
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
Hitchon CA; Chandad F; Ferucci ED; Willemze A; Ioan-Facsinay A; van der Woude D; Markland J; Robinson D; Elias B; Newkirk M; Toes RM; Huizinga TW; El-Gabalawy HS
J Rheumatol; 2010 Jun; 37(6):1105-12. PubMed ID: 20436074
[TBL] [Abstract][Full Text] [Related]
16. The ACPA recognition profile and subgrouping of ACPA-positive RA patients.
Willemze A; Böhringer S; Knevel R; Levarht EW; Stoeken-Rijsbergen G; Houwing-Duistermaat JJ; van der Helm-van Mil AH; Huizinga TW; Toes RE; Trouw LA
Ann Rheum Dis; 2012 Feb; 71(2):268-74. PubMed ID: 21998120
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D
Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
[TBL] [Abstract][Full Text] [Related]
18. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production.
Lu MC; Lai NS; Yu HC; Huang HB; Hsieh SC; Yu CL
Arthritis Rheum; 2010 May; 62(5):1213-23. PubMed ID: 20213805
[TBL] [Abstract][Full Text] [Related]
19. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.
Feitsma AL; Toes RE; Begovich AB; Chokkalingam AP; de Vries RR; Huizinga TW; van der Helm-van Mil AH
Rheumatology (Oxford); 2007 Jul; 46(7):1092-5. PubMed ID: 17341507
[TBL] [Abstract][Full Text] [Related]
20. Association between body mass index and anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis: results from a population-based case-control study.
Wesley A; Bengtsson C; Elkan AC; Klareskog L; Alfredsson L; Wedrén S;
Arthritis Care Res (Hoboken); 2013 Jan; 65(1):107-12. PubMed ID: 22674870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
